Cytologic grade independently predicts survival of patients with pancreatic adenocarcinoma

American Journal of Clinical Pathology

Volumn 124, Issue 5, 2005, Pages 697-707

  Eltoum, Isam A ^a,d   Eloubeidi, Mohamad A ^b   Chhieng, David C ^c   Tamhane, Ashutosh ^b   Crowe, Ralph ^a   Jhala, Darshana ^a   St John, Kay D ^a   Wilcox, C Mel ^b   Siegal, Gene P ^a   Vickers, Selwyn ^c   Jhala, Nirag C ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c Kentucky   (United States)

^d NONE   (United States)

Author keywords

Endoscopic ultrasound fine needle aspiration; Pancreatic adenocarcinoma; Prognosis; Tumor grade; Tumor stage

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; ENDOSCOPE; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEEDLE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AZURE STAINS; EOSINE YELLOWISH-(YS); FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS;

EID: 27444433361     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/044PL9GT0C3DB4N4     Document Type: Article

References (36)

1. American Cancer Society. Detailed guide: pancreatic cancer: what are the key statistics about pancreatic cancer? American Cancer Society; 2004. Available at http://www.cancer.org/ docroot/CR1/content/ CRI_2_4_1X_What_are_the_key_statistics_for_pancreatic_cancer_34.asp?sitearea=. Accessed September 2004.
2. Greene FL, Page DL, Fleming ID, et al (American Joint Committee on Cancer), eds. AJCC Cancer Staging Handbook: From the AJCC Staging Manual. 6th ed. New York, NY: Springer New York; 2002.
3. Hermanek P. Pathology and biology of pancreatic ductal adenocarcinoma. Langenbecks Arch Surg. 1998;383:116-120.
4. Abrams RA. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys. 2003;56(4 suppl):3-9.
5. Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998;228:429-438.
6. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
7. Birkmeyer JD, Finlayson SR, Tosteson AN, et al. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery. 1999;25:250-256.
8. Birkmeyer JD, Warshaw AL, Finlayson SR, et al. Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery. 1999;126:178-183.
9. Lin F, Staerkel G. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens. Cancer. 2003;99:44-50.
10. Robins DB, Katz RL, Evans DB, et al. Fine needle aspiration of the pancreas: in quest of accuracy. Acta Cytol. 1995;39:1-10.
11. Enayati PG, Traverso LW, Galagan K, et al. The meaning of equivocal pancreatic cytology in patients thought to have pancreatic cancer. Am J Surg. 1996;171:525-528.
12. Hughes JH, Cohen MB. Fine-needle aspiration of the pancreas. Pathology (Phila). 1996;4:389-407.
13. Eloubeidi MA, Jhala D, Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer. 2003;99:285-292.
14. Chhieng DC, Jhala D, Jhala N, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases. Cancer. 2002;96:232-239.
15. Ylagan LR, Edmundowicz S, Kasal K, et al. Endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic carcinoma: a 3-year experience and review of the literature. Cancer. 2002;96:362-369.
16. Raut CP, Grau AM, Staerkel GA, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg. 2003;7:118-128.
17. Hernandez LV, Mishra G, Forsmark C, et al. Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas. Pancreas. 2002;25:222-228.
18. Shin HJ, Lahoti S, Sneige N. Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the M.D. Anderson Cancer Center experience. Cancer. 2002;96:174-180.
19. Bhutani MS, Hawes RH, Baron PL, et al. Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic lesions. Endoscopy. 1997;29:854-858.
20. Chang KJ, Albers CG, Erickson RA, et al. Endoscopic ultrasound-guided fine needle aspiration of pancreatic carcinoma. Am J Gastroenterol. 1994;89:263-266.
21. Jhala NC, Jhala DN, Chhieng DC, et al. Endoscopic ultrasound-guided fine-needle aspiration: a cytopathologist's perspective. Am J Clin Pathol. 2003;120:351-367.
22. Kloppel G, Lingenthal G, von Bulow M, et al. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology. 1985;9:841-856.
23. Luttges J, Schemm S, Vogel I, et al. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000;191:154-161.
24. Dong M, Nio Y, Yamasawa K, et al. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. J Surg Oncol. 2003;82:111-120.
25. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758-768.
26. Iacono C, Accordini S, Bortolasi L, et al. Results of pancreaticoduodenectomy for pancreatic cancer: extended versus standard procedure. World J Surg. 2002;26:1309-1314.
27. Sperti C, Pasquali C, Piccoli A, et al. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 1996;83:625-631.
28. Yeo CJ, Abrams RA, Grochow LB, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival: a prospective, single-institution experience. Ann Surg. 1997;225:621-636.
29. Kim T, Murakami T, Takamura M, et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol. 2001;177:367-371.
30. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003;237:853-859.
31. Coen H, Kint H, Kuyper CF, et al. Growth behavior of human pancreatic carcinoma xenograft correlates with nuclear features. Cytometry. 1992;13:775-781.
32. Tannapfel A, Wittekind C, Hunefeld G. Ductal adenocarcinoma of the pancreas: histopathological features and prognosis. Int J Pancreatol. 1992;12:145-152.
33. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas: 616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-579.
34. Janes RH Jr, Niederhuber JE, Chmiel JS, et al. National patterns of care for pancreatic cancer: results of a survey by the Commission on Cancer. Ann Surg. 1996;223:261-272.
35. DiMagno EP. Pancreatic cancer: clinical presentation, pitfalls and early clues. Ann Oncol. 1999;10(suppl 4):140-142.
36. Adsay NV, Basturk O, Bonnett M, et al. A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2005;29:724-733.